Healthy Volunteers Trial

Recruiting people aged 60-80 and don’t have any particular memory concerns or an Alzheimer’s diagnosis to take part in a trial to help identify some new treatments.

Qualifications:

  • They are aged 60-80.
  • Have a study partner (a friend or relative) to accompany them for some visits.
  • If you have not had a stroke in the last 12 months or active cancer.

Relevant dates:

  • Always available – people can jump in at anytime
11
22

  • Fill in your details below to get more information about our free voluntary research.

    Step 1 of 2

Benefits of attending

  • Free, thorough health screening, including MRI scans & PET scans.
  • Feel confidence in your health report with expert feedback & care at no extra cost
  • Participate in low-stress & low-anxiety trial testing, including free genetic testing
  • Volunteers get early access to new, advanced treatments for memory loss
  • Travel expenses are reimbursed for each visit

  • “I have received immaculate care and understanding”

    Re:Cognition Health Patient

  • “The range of tests, and the subsequent feedback, were so thorough and reassuring.”

    Re:Cognition Health Patient

  • “Without exception, all the staff are fantastic! Making you feel at ease. Nothing is too much trouble.”

    Re:Cognition Health Patient

About

Re:Cognition Health (RCH) opened as a private independent service provider in 2011, specializing in cognitive health. The company later expanded the scope of its services to include medical-legal and clinical research. It was founded by Dr. Emer MacSweeney, CEO  (UK Citizen & resident), and Tom Dent, Chairman (USA Citizen & resident).

The portfolio currently includes 5 centers in the United Kingdom and 1 center in the USA. The first clinical trial center in the USA opened in May 2018. The USA portfolio has additional centers planned in 2020. Today Re:Cognition Health is recognized as the leading independent provider of Center services for cognitive disorders with a successful award-winning business in:

  • Adult-acquired and progressive neurodegenerative diseases
  • Traumatic Brain injury –including medicolegal witness reporting and rehabilitation
  •  International Clinical Trials for Alzheimer’s Disease (AD) and other Central Nervous System (CNS) disorders